iTeos Therapeutics is a privately-held, clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing next generation immunotherapies. iTeos Therapeutics is advancing its two main programs into a phase I/II clinical stage. The first program is an insurmountable and non-brain penetrant adenosine A2A receptor antagonist. The second program is a human ADCC-enabling anti-TIGIT antibody.
Based in Gosselies, Belgium and Cambridge, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute (UCLouvain) in 2011. In March 2020, the Company completed a $125 million Series B2 financing led by 6 main US Venture Capitalists. All previous investors including Fund +, VIVES II and SRIW, as well as SFPI, also participated in this funding round. For more information, please visit www.iteostherapeutics.com.
iTeos Therapeutics is now a world-class actor in the sector. To carry on its growth and reinforce its team, iTeos Therapeutics is looking for a (m/f) :
Senior Scientist – Translational Medicine in immuno-oncology
Within its Translational Medicine Department, iTeos is currently actively looking for a highly motivated and creative Senior Scientist with expertise in immuno-oncology or immunology research to take a leading role supporting the discovery of biomarkers for pharmaco-dynamic analysis and patient selection. With a role of Translational Medicine expert in the project team(s), the selected candidate will work in close interaction with the other departments to select the biomarkers, ensure access to state of the art technologies, evaluate their scientific basis and clinical applicability. He/she will assess the qualification/validation status and technical or statistical issues related to the proposed biomarker assays. In addition to this, he/she will play a key role in directing the development and outsourcing of clinically applicable biomarker assays and oversee the analysis and reporting of the data. Moreover, in close interaction with the clinical team, he/she will coordinate translational activities to build a scientific rationale to support the clinical strategy.
More specifically, the responsibilities will be to :
- Actively participate and lead the definition, development and implementation of biomarker strategies for diverse projects in close interaction with the members of the project team(s).
- Coordinate translational scientific activities, internally and in collaboration with academic partners, to build a scientific rationale to select indications to support the clinical strategy of the project(s).
- Manage the selection, development, qualification/validation of clinically applicable biomarker assays including pharmacodynamic, predictive, prognostic, and safety biomarkers internally and/or in external analytical laboratories.
- Ensure the feasibility of such assays in a clinical setting and support their implementation in clinical trials. This includes the review of dedicated sections of clinical documents and other material needed, and requires a close interaction with the Clinical teams and external service providers.
- Oversee pharmacodynamic and patient selection biomarker testing and complex data analysis across several functional areas.
- Mentor the experimental work of research assistant(s) and/or scientist(s).
- Participate to experimental work to facilitate and assist with biomarker assay development and/or qualification.
- PhD, MD/PhD in Cancer Biology, Immunology, Cell, or Molecular Biology with a minimum of 5 years of relevant post-doctoral research experience in analyzing human samples and/or monitoring analysis of biological markers during clinical trials. Must have expertise in immuno-oncology or immunology.
- Experience with the discovery, characterization, clinical application of biomarkers using flow cytometry, proteomics, molecular biology or immunohistochemistry of human tissue specimens.
- Direct experience in qualification/validation, development, and outsourcing of clinically applicable pharmacodynamic biomarker assays.
- Experience in implementing bio-assays in clinical studies.
- Fluent in English (oral and written). French is a plus.
- Strong project and interpersonal
- Strongly organized and rigorous, you have a good ability to adapt to changes in priorities and to work effectively on multiple immune oncology programs in a fast paced environment.
- Although autonomous, you have a high ability to collaborate with internal and external stakeholders.
- Strong motivation, attention to details.
- A stimulating scientific position within a high-potential innovative biotech company.
- The opportunity to work in a science-driven, dynamic, human‐sized, respectful and professional environment.
- A challenging scientific and business growth in which you get to bring your knowledge and skills.
- Varied contacts inside the company, the biotech/pharma sector and the scientific world.
- A long-term contract and an attractive salary package in line with the position responsibilities and your experience.